Last C$1.29 CAD
Change Today -0.01 / -0.77%
Volume 6.4K
AEZ On Other Exchanges
Symbol
Exchange
Toronto
NASDAQ CM
Frankfurt
As of 1:08 PM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gérard Antoine Limoges CM, FCPA, FCA

Director, Chairman of Audit Committee and Director of Atrium Biotechnologies Inc , Aeterna Zentaris Inc.
AgeTotal Calculated CompensationThis person is connected to 104 board members in 9 different organizations across 10 different industries.

See Board Relationships
73$74,916

Background*

Mr. Gérard Antoine Limoges, CM, FCPA, FCA, has been the President of Ernst & Young for the Province of Quebec since 1984. Mr. Limoges has vast experience in Accounting, Auditing, Consulting, Mergers and Acquisitions in a wide spectrum of industries. He has a long experience in the areas of accounting, audit, mergers and acquisitions and has worked for clients in a wide range of industries including service companies, retail, communications, transportation, real estate, ...

Read Full Background

Corporate Headquarters*

1405 du Parc-Technologique Boulevard
Quebec City, Quebec G1P 4P5

Canada

Phone: 418-652-8525
Fax: 418-948-9191

Board Members Memberships*

Director, Member of Audit Committee and Member of Ethics Committee
Chairman
1999-N/A
Former Director, Member of Audit Committee and Member of Governance & Compensation Committee
2002-2007
Former Trustee, Chairman of Audit Committee, Chairman of Transaction Committee, Member of Governance Committee and Member of Human Resources & Compensation Committee
2003-Present
Lead Director, Chairman of Audit Committee and Member of Corporate Governance Committee
2003-Present
Independent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Corporate Governance Committee
2003-Present
Director, Chairman of Audit Committee, Member of Governance Committee, Member of Compensation Committee and Member of Strategic Review Committee
2004-Present
Director, Chairman of Audit Committee and Director of Atrium Biotechnologies Inc
2004-2006
Former Director
2004-Present
Director, Chairman of Audit Committee and Chairman of Independent Committee
2007-2010
Former Independent Trustee of Noranda Operating Trust, Chairman of Governance & Nominating Committee, Member of Independent Committee and Member of Audit Committee
2010-2012
Former Independent Trustee, Chairman of Audit Committee, Member of Compensation Committee, Member of Governance Committee, Member of Nominating Committee and Member of Investment Committee
2013-Present
Independent Director and Chairman of Audit Committee

Education*

Bachelor's Degree 1966
Ecole des Hautes Etudes Commerciales de Montreal

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Total Value of OptionsC$6,500

Total Compensation*

Total Annual Cash Compensation$44,885
Total Calculated Compensation$74,916
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AEZ:CN C$1.29 CAD -0.01

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AETERNA ZENTARIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.